380 related articles for article (PubMed ID: 15948867)
1. Ultrastructural analysis of the Fisher to Lewis rat model of chronic allograft nephropathy.
Hamar P; Lipták P; Heemann U; Iványi B
Transpl Int; 2005 Jul; 18(7):863-70. PubMed ID: 15948867
[TBL] [Abstract][Full Text] [Related]
2. The value of electron microscopy in the diagnosis of chronic renal allograft rejection.
Ivanyi B; Kemeny E; Szederkenyi E; Marofka F; Szenohradszky P
Mod Pathol; 2001 Dec; 14(12):1200-8. PubMed ID: 11743041
[TBL] [Abstract][Full Text] [Related]
3. Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens.
de Heer E; Davidoff A; van der Wal A; van Geest M; Paul LC
Lab Invest; 1994 Apr; 70(4):494-502. PubMed ID: 8176888
[TBL] [Abstract][Full Text] [Related]
4. A new alloantigen-independent control for chronic allograft nephropathy rat models.
Chang SH; Park HK; Eryilmaz R; Bu D; Stone JJ; Massey D; Riley RS; Fisher RA
J Surg Res; 2005 Sep; 128(1):50-4. PubMed ID: 16115492
[TBL] [Abstract][Full Text] [Related]
5. Infections and reduced functioning kidney mass induce chronic rejection in rat kidney allografts.
Heemann UW; Azuma H; Tullius SG; Schmid C; Philipp T; Tilney NL
Clin Nephrol; 1996 Jul; 46(1):34-8. PubMed ID: 8832148
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
[TBL] [Abstract][Full Text] [Related]
7. The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats.
Heemann UW; Azuma H; Tullius SG; Mackenzie H; Brenner BM; Tilney NL
Transplantation; 1994 Dec; 58(12):1317-22. PubMed ID: 7528948
[TBL] [Abstract][Full Text] [Related]
8. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
Revelo MP; Federspiel C; Helderman H; Fogo AB
Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
[TBL] [Abstract][Full Text] [Related]
9. Fisher-Lewis kidney transplantation model as a tool for investigation of transplantation-induced cardiomyopathy.
Baumann M; Chang J; Thürmel K; Roos M; von Eynatten M; Sollinger D; Lutz J; Heemann U
Transplant Proc; 2009; 41(6):2612-5. PubMed ID: 19715985
[TBL] [Abstract][Full Text] [Related]
10. Immune Complex-Type Deposits in the Fischer-344 to Lewis Rat Model of Renal Transplantation and a Subset of Human Transplant Glomerulopathy.
Grau V; Zeuschner P; Immenschuh S; Bockmeyer CL; Zell S; Wittig J; Säuberlich K; Abbas M; Padberg W; Meyer-Schwesinger C; von Brandenstein M; Schlosser M; Dieplinger G; Galliford J; Clarke C; Roufosse C; Becker JU
Transplantation; 2016 May; 100(5):1004-14. PubMed ID: 26895216
[TBL] [Abstract][Full Text] [Related]
11. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
[TBL] [Abstract][Full Text] [Related]
12. Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.
Joosten SA; van Dixhoorn MG; Borrias MC; Benediktsson H; van Veelen PA; van Kooten C; Paul LC
Am J Pathol; 2002 Apr; 160(4):1301-10. PubMed ID: 11943715
[TBL] [Abstract][Full Text] [Related]
13. Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury.
Tullius SG; Hancock WW; Heemann U; Azuma H; Tilney NL
Transplantation; 1994 Jul; 58(1):93-9. PubMed ID: 8036713
[TBL] [Abstract][Full Text] [Related]
14. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
[TBL] [Abstract][Full Text] [Related]
15. Effects of everolimus on cellular and humoral immune processes leading to chronic allograft nephropathy in a rat model with sensitized recipients.
Koch M; Mengel M; Poehnert D; Nashan B
Transplantation; 2007 Feb; 83(4):498-505. PubMed ID: 17318083
[TBL] [Abstract][Full Text] [Related]
16. Expression of the integrin-linked kinase in a rat kidney model of chronic allograft nephropathy.
Han C; Zou H; Li Q; Wang Y; Shi Y; Lv T; Chen L; Zhou W
Cell Biochem Biophys; 2011 Sep; 61(1):73-81. PubMed ID: 21350838
[TBL] [Abstract][Full Text] [Related]
17. Augmenting kidney mass at transplantation abrogates chronic renal allograft injury in rats.
Mackenzie HS; Azuma H; Troy JL; Rennke HG; Tilney NL; Brenner BM
Proc Assoc Am Physicians; 1996 Mar; 108(2):127-33. PubMed ID: 8705732
[TBL] [Abstract][Full Text] [Related]
18. Functional and histologic characteristics of chronic renal allograft rejection.
Paul LC
Clin Transplant; 1994 Jun; 8(3 Pt 2):319-23. PubMed ID: 8061373
[TBL] [Abstract][Full Text] [Related]
19. Chronic allograft nephropathy in athymic nude rats after adoptive transfer of primed T lymphocytes.
Doege C; Koch M; Heratizadeh A; Sótonyi P; Mengel M; Nashan B
Transpl Int; 2005 Aug; 18(8):981-91. PubMed ID: 16008750
[TBL] [Abstract][Full Text] [Related]
20. The involvement of activated T cells and growth-factor production in the early and late phase of chronic kidney allograft nephropathy in rats.
Hamar P; Szabó A; Müller V; Heemann U
Transpl Int; 2002 Oct; 15(9-10):446-54. PubMed ID: 12389075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
